Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, January, 2006 - Advertising

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October to December 2005 inclusive

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October to December 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com.

BD Medical

Portfolio

Regional anaesthesia

Mason Zimbler

Bristol-Myers Squibb

New product

Ultrasound contrast agents

PAN Advertising

Cardinal Health Martindale Products

Pre-filled syringes

Hospital speciality

Pulsar Healthcare Communications

Frontier Medical

Repose

Tissue viability

Mason Zimbler

GE Healthcare Discovery Systems

New product

N/A

Seven Stones

Genosis

Fertell

Fertility

Dewar Alexander

Gilead Sciences

AmBisome

Antifungal

FCB Healthcare

GrÈnenthal

Clarosip

Antibiotic

MJL Advertising

Janssen-Cilag Ireland

Durogesic D-Trans

Pain relief

MJL Advertising

Mayne Pharma

N/A

Full portfolio

Swordfish Advertising

Nutricia Clinical Care

Glutafin

Nutrition

Life

Roche

Tarceva

Oncology

MJL Advertising

2nd September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics